Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-31
DOI
10.3389/fimmu.2019.02545
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients
- (2019) H. Cabanas et al. MOLECULAR MEDICINE
- Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- (2018) Jose Luis Rivas et al. Frontiers in Immunology
- Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
- (2018) Hélène Cabanas et al. MOLECULAR MEDICINE
- G protein βγ subunits inhibit TRPM3 ion channels in sensory neurons
- (2017) Talisia Quallo et al. eLife
- Inhibition of Transient Receptor Potential Melastatin 3 ion channels by G-protein βγ subunits
- (2017) Doreen Badheka et al. eLife
- Anti-nociceptive action of peripheral mu-opioid receptors by G-beta-gamma protein-mediated inhibition of TRPM3 channels
- (2017) Sandeep Dembla et al. eLife
- Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors
- (2017) Rachel Cant et al. Frontiers in Immunology
- Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
- (2017) Jakob Theorell et al. Frontiers in Immunology
- Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels
- (2016) T. Nguyen et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
- (2015) Sharni Lee Hardcastle et al. BMC IMMUNOLOGY
- Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis
- (2015) T. K. Huth et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- GPCR: G protein complexes—the fundamental signaling assembly
- (2013) Beata Jastrzebska AMINO ACIDS
- Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome
- (2013) Marta Curriu et al. Journal of Translational Medicine
- Calcium signalling remodelling and disease
- (2012) Michael J. Berridge BIOCHEMICAL SOCIETY TRANSACTIONS
- Calcium, cancer and killing: The role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells
- (2012) Eva C. Schwarz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Citrus fruit and fabacea secondary metabolites potently and selectively block TRPM3
- (2012) I Straub et al. BRITISH JOURNAL OF PHARMACOLOGY
- Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis
- (2012) Ekua W Brenu et al. Journal of Translational Medicine
- Role of the mu-opioid receptor in opioid modulation of immune function
- (2011) Jana Ninković et al. AMINO ACIDS
- Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled Trial
- (2011) Jill P. Smith et al. DIGESTIVE DISEASES AND SCIENCES
- Myalgic encephalomyelitis: International Consensus Criteria
- (2011) B. M. Carruthers et al. JOURNAL OF INTERNAL MEDICINE
- Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
- (2011) Ekua W Brenu et al. Journal of Translational Medicine
- TRPM3 Is a Nociceptor Channel Involved in the Detection of Noxious Heat
- (2011) Joris Vriens et al. NEURON
- Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis
- (2010) Bruce A. C. Cree et al. ANNALS OF NEUROLOGY
- Paired NK cell receptors controlling NK cytotoxicity
- (2010) Noa Stanietsky et al. FEBS LETTERS
- Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26
- (2010) Mary A. Fletcher et al. PLoS One
- The Role of Transient Receptor Potential Cation Channels in Ca2+ Signaling
- (2010) M. Gees et al. Cold Spring Harbor Perspectives in Biology
- Opioid-Like Activity of Naltrexone on Natural Killer Cell Cytolytic Activity and Cytokine Production in Splenocytes: Effects of Alcohol
- (2009) Nadka I. Boyadjieva et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Effects of Naltrexone on Pain Sensitivity and Mood in Fibromyalgia: No Evidence for Endogenous Opioid Pathophysiology
- (2009) Jarred W. Younger et al. PLoS One
- Normative Data for the 12 Item WHO Disability Assessment Schedule 2.0
- (2009) Gavin Andrews et al. PLoS One
- Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications
- (2008) Jo Nijs et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started